Plasma circulating nucleic acids levels increase according to the morbidity of plasmodium vivax malaria

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Franklin, Bernardo S ^a   Vitorino, Barbara L F ^a   Coelho, Helena C ^b   Menezes Neto, Armando ^a   Santos, Marina L S ^a   Campos, Fernanda M F ^a   Brito, Cristiana F ^a   Fontes, Cor J ^c   Lacerda, Marcus V ^b   Carvalho, Luzia H ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DOUBLE STRANDED DNA; NUCLEIC ACID; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; FLUOROMETRY; GENE AMPLIFICATION; GENE SEQUENCE; HOST PARASITE INTERACTION; HUMAN; MALE; MORBIDITY; NUCLEIC ACID ANALYSIS; PLASMA CIRCULATING NUCLEIC ACID LEVEL; PLASMODIUM VIVAX MALARIA; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; BLOOD; DRUG EFFECT; GENETICS; GENOME; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX;

PLASMODIUM VIVAX;

ADULT; AGED; ANTIMALARIALS; BASE SEQUENCE; BRAZIL; FEMALE; GENOME; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; NUCLEIC ACIDS; PLASMODIUM VIVAX; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 79956068284     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019842     Document Type: Article

References (59)

1. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774.
2. Kochar D, Saxena V, Singh N, Kochar S, Kumar S, et al. (2005) Plasmodium vivax malaria. Emerg Infect Dis 11: 132-134.
3. Kochar D, Das A, Kochar S, Saxena V, Sirohi P, et al. (2009) Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 80: 194-198.
4. Poespoprodjo J, Fobia W, Kenangalem E, Lampah D, Hasanuddin A, et al. (2009) Vivax malaria: a major cause of morbidity in early infancy. Clin Infect Dis 48: 1704-1712.
5. Tjitra E, Anstey N, Sugiarto P, Warikar N, Kenangalem E, et al. (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128.
6. Genton B, D'Acremont V, Rare L, Baea K, Reeder J, et al. (2008) Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 5: e127.
7. Alexandre M, Ferreira C, Siqueira A, Magalhães B, Mourão M, et al. (2010) Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis 16: 1611-1614.
8. Anstey N, Russell B, Yeo T, Price R, (2009) The pathophysiology of vivax malaria. Trends Parasitol 25: 220-227.
9. Hemmer C, Holst F, Kern P, Chiwakata C, Dietrich M, et al. (2006) Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 11: 817-823.
10. Campos F, Franklin B, Teixeira-Carvalho A, Filho A, de Paula S, et al. (2010) Augmented plasma microparticles during acute Plasmodium vivax infection. Malar J 9: 327.
11. Karunaweera N, Grau G, Gamage P, Carter R, Mendis K, (1992) Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci U S A 89: 3200-3203.
12. Andrade B, Reis-Filho A, Souza-Neto S, Clarencio J, Camargo L, et al. (2010) Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J 9: 13.
13. Karunaweera N, Wijesekera S, Wanasekera D, Mendis K, Carter R, (2003) The paroxysm of Plasmodium vivax malaria. Trends Parasitol 19: 188-193.
14. Andrade BB, Reis-Filho A, Souza-Neto SM, Raffaele-Netto I, Camargo LM, et al. (2010) Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. PLoS Negl Trop Dis 4: e650.
15. Mandel P, Metais P, (1948) Les acides nucleiques du plasma sanguine chez I'homme. C R Acad Sci Paris 142.
16. Leon S, Shapiro B, Sklaroff D, Yaros M, (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650.
17. Chen J, Meister S, Urbonaviciute V, Rödel F, Wilhelm S, et al. (2007) Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus. Autoimmunity 40: 307-310.
18. Koffler D, Agnello V, Winchester R, Kunkel H, (1973) The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest 52: 198-204.
19. Rani S, Clynes M, O'Driscoll L, (2007) Detection of amplifiable mRNA extracellular to insulin-producing cells: potential for predicting beta cell mass and function. Clin Chem 53: 1936-1944.
20. Lam N, Rainer T, Chan L, Joynt G, Lo Y, (2003) Time course of early and late changes in plasma DNA in trauma patients. Clin Chem 49: 1286-1291.
21. Lam NY, Rainer TH, Wong LK, Lam W, Lo YM, (2006) Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset. Resuscitation 68: 71-78.
22. Antonatos D, Patsilinakos S, Spanodimos S, Korkonikitas P, Tsigas D, (2006) Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann N Y Acad Sci 1075: 278-281.
23. Chang CP, Chia RH, Wu TL, Tsao KC, Sun CF, et al. (2003) Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta 327: 95-101.
24. Moreira VG, Prieto B, Rodríguez JS, Alvarez FV, (2010) Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann Clin Biochem 47: 253-258.
25. Butt A, Swaminathan R, (2008) Overview of circulating nucleic acids in plasma/serum. Ann N Y Acad Sci 1137: 236-242.
26. Ombrello C, Block RC, Morrell CN, (2010) Our expanding view of platelet functions and its clinical implications. J Cardiovasc Transl Res 3: 538-546.
27. Cox D, McConkey S, (2010) The role of platelets in the pathogenesis of cerebral malaria. Cell Mol Life Sci 67: 557-568.
28. Araujo C, Lacerda M, Abdalla D, Lima E, (2008) The role of platelet and plasma markers of antioxidant status and oxidative stress in thrombocytopenia among patients with vivax malaria. Mem Inst Oswaldo Cruz 103: 517-521.
29. Ellinger J, Müller S, Stadler T, Jung A, von Ruecker A, et al. (2009) The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer. Urol Oncol.
30. Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, et al. (2001) Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61: 4675-4678.
31. Umetani N, Kim J, Hiramatsu S, Reber H, Hines O, et al. (2006) Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem 52: 1062-1069.
32. Trejo-Becerril C, Pérez-Cárdenas E, Treviño-Cuevas H, Taja-Chayeb L, García-López P, et al. (2003) Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients. Int J Cancer 104: 663-668.
33. Chang HW, Lee SM, Goodman SN, Singer G, Cho SK, et al. (2002) Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst 94: 1697-1703.
34. Huang ZH, Li LH, Hua D, (2006) Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett 243: 64-70.
35. Ellinger J, Wittkamp V, Albers P, Perabo F, Mueller S, et al. (2009) Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol 181: 363-371.
36. Ellinger J, Bastian P, Ellinger N, Kahl P, Perabo F, et al. (2008) Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity. Cancer Lett 264: 274-280.
37. Jung K, Stephan C, Lewandowski M, Klotzek S, Jung M, et al. (2004) Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer. Cancer Lett 205: 173-180.
38. Jakobsen P, Morris-Jones S, Rønn A, Hviid L, Theander T, et al. (1994) Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology 83: 665-669.
39. Kern P, Hemmer CJ, Van Damme J, Gruss HJ, Dietrich M, (1989) Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 87: 139-143.
40. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, et al. (1999) Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64: 218-224.
41. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, et al. (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61: 1659-1665.
42. Atamaniuk J, Ruzicka K, Stuhlmeier KM, Karimi A, Eigner M, et al. (2006) Cell-free plasma DNA: a marker for apoptosis during hemodialysis. Clin Chem 52: 523-526.
43. Lovegrove F, Gharib S, Patel S, Hawkes C, Kain K, et al. (2007) Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria. Am J Pathol 171: 1894-1903.
44. Miu J, Hunt N, Ball H, (2008) Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis. Infect Immun 76: 1812-1824.
45. van der Vaart M, Pretorius P, (2008) Circulating DNA. Its origin and fluctuation. Ann N Y Acad Sci 1137: 18-26.
46. Shaikh Q, Ahmad S, Abbasi A, Malik S, Sahito A, et al. (2009) Thrombocytopenia in malaria. J Coll Physicians Surg Pak 19: 708-710.
47. Kochar DK, Tanwar GS, Khatri PC, Kochar SK, Sengar GS, et al. (2010) Clinical features of children hospitalized with malaria-a study from Bikaner, northwest India. Am J Trop Med Hyg 83: 981-989.
48. Kochar DK, Das A, Kochar A, Middha S, Acharya J, et al. (2010) Thrombocytopenia in Plasmodium falciparum, Plasmodium vivax and mixed infection malaria: a study from Bikaner (Northwestern India). Platelets 21: 623-627.
49. Anker P, Stroun M, (2002) Progress in the knowledge of circulating nucleic acids: plasma RNA is particle-associated. Can it become a general detection marker for a cancer blood test? Clin Chem 48: 1210-1211.
50. WHO (2000) Severe falciparum malaria. 90p.
51. Kono H, Rock KL, (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-289.
52. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, et al. (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330: 362-366.
53. Hornung V, Latz E, (2010) Intracellular DNA recognition. Nat Rev Immunol 10: 123-130.
54. Saraiva M, Amorim R, Moura M, Martinez-Espinosa F, Barbosa M, (2009) [Urban expansion and spatial distribution of malaria in the municipality of Manaus, State of Amazonas]. Rev Soc Bras Med Trop 42: 515-522.
55. Oliveira-Ferreira J, Lacerda M, Brasil P, Ladislau J, Tauil P, et al. (2010) Malaria in Brazil: an overview. Malar J 9: 115.
56. Karunaweera N, Carter R, Grau G, Mendis K, (1998) Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease. Am J Trop Med Hyg 58: 204-210.
57. Souza-Silva FA, da Silva-Nunes M, Sanchez BA, Ceravolo IP, Malafronte RS, et al. (2010) Naturally acquired antibodies to Plasmodium vivax Duffy binding protein (DBP) in Brazilian Amazon. Am J Trop Med Hyg 82: 185-193.
58. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, et al. (2003) Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21: 3902-3908.
59. Carlton J, Adams J, Silva J, Bidwell S, Lorenzi H, et al. (2008) Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455: 757-763.